1. Home
  2. UTMD vs MDWD Comparison

UTMD vs MDWD Comparison

Compare UTMD & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utah Medical Products Inc.

UTMD

Utah Medical Products Inc.

HOLD

Current Price

$63.80

Market Cap

206.5M

Sector

Health Care

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.40

Market Cap

212.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTMD
MDWD
Founded
1978
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.5M
212.1M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
UTMD
MDWD
Price
$63.80
$16.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
6.4K
53.9K
Earning Date
04-23-2026
05-20-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
N/A
EPS
0.82
N/A
Revenue
$38,520,000.00
N/A
Revenue This Year
N/A
$48.92
Revenue Next Year
N/A
$35.04
P/E Ratio
$78.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$52.00
$14.90
52 Week High
$71.81
$22.51

Technical Indicators

Market Signals
Indicator
UTMD
MDWD
Relative Strength Index (RSI) 38.48 46.14
Support Level $60.23 $16.31
Resistance Level $64.21 $18.38
Average True Range (ATR) 1.42 0.51
MACD -0.36 -0.04
Stochastic Oscillator 16.39 30.10

Price Performance

Historical Comparison
UTMD
MDWD

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: